The Regulatory Environment of Telemedicine After COVID-19.
Document Type
Article
Publication Date
10-2022
Identifier
DOI: 10.1016/j.jaip.2022.07.001; PMCID: PMC9277986
Abstract
The COVID-19 pandemic has created many barriers to providing health care, yet it also has created new opportunities. Although telemedicine was a nascent means of health care delivery before COVID-19, it now is one of the principal means for doing so today, and it is likely to remain so. Whether this will happen may depend in part on continued relaxation of regulations that hampered it before the pandemic. Whereas enforcement of compliance with Health Information Portability and Accountability Act will most likely resume, platform operators and providers have had an opportunity to prepare for this. State licensure requirements may also resume; however, the regulations were in the process of becoming more liberal before COVID-19 so that process might continue. There is no reason to anticipate that payment for telemedicine services including check-ins, remote physiologic and therapeutic monitoring, and relaxation of location and service requirements will end. For these reasons, telemedicine therefore is likely to continue as an important part of medical practice.
Journal Title
J Allergy Clin Immunol Pract
Volume
10
Issue
10
First Page
2500
Last Page
2505
MeSH Keywords
COVID-19; Delivery of Health Care; Humans; Pandemics; Telemedicine
Keywords
E consults; Licensing; Remote patient monitoring; Telemedicine
Recommended Citation
Pandya A, Waller M, Portnoy JM. The Regulatory Environment of Telemedicine After COVID-19. J Allergy Clin Immunol Pract. 2022;10(10):2500-2505. doi:10.1016/j.jaip.2022.07.001
COinS
